Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.02.2024 | Case report

Immunosuppressants

Hemophagocytic lymphohistiocytosis and candidiasis

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Xu G, et al. Successful use of subcutaneous anakinra in hemophagocytic lymphohistiocytosis precipitated by candidiasis in a patient with systemic lupus erythematosus: A case report and description of a novel therapeutic regimen. International Journal of Rheumatic Diseases 26: 2284-2287, No. 11, Jan 2023. Available from: URL: https://dx.doi.org/10.1111/1756-185X.14722 Xu G, et al. Successful use of subcutaneous anakinra in hemophagocytic lymphohistiocytosis precipitated by candidiasis in a patient with systemic lupus erythematosus: A case report and description of a novel therapeutic regimen. International Journal of Rheumatic Diseases 26: 2284-2287, No. 11, Jan 2023. Available from: URL: https://​dx.​doi.​org/​10.​1111/​1756-185X.​14722
Metadaten
Titel
Immunosuppressants
Hemophagocytic lymphohistiocytosis and candidiasis
Publikationsdatum
01.02.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-53186-7

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Dyclonine

Case report

Sitafloxacin